Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DSA”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Large-scale testing (Phase 3)Study completedNCT00185276
What this trial is testing

Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries

Who this might be right for
Peripheral Vascular Disease
Bayer 365
Post-approval studies (Phase 4)Study completedNCT01075217
What this trial is testing

Isovue in Peripheral Digital Subtraction Angiography (DSA)

Who this might be right for
Peripheral Arterial Occlusive Disease
Bracco Diagnostics, Inc 174
Not applicableStudy completedNCT05247177
What this trial is testing

Multimodal GA for Lumbar Spine Surgery

Who this might be right for
Lumbar Spine Fusion Surgery
National Taiwan University Hospital 100
Not applicableStudy completedNCT03798860
What this trial is testing

Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

Who this might be right for
Lung TransplantationDonor-specific Anti-human Leukocyte Antigen(HLA) Antibodies
Hannover Medical School 340
Post-approval studies (Phase 4)Study completedNCT00740207
What this trial is testing

Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA

Who this might be right for
Peripheral Arterial Occlusive Disease
Bracco Diagnostics, Inc 33
Not applicableLooking for participantsNCT03291652
What this trial is testing

Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential

Who this might be right for
Ischemic StrokeAtheroscleroses, Cerebral
Chinese University of Hong Kong 140
Not applicableActive Not RecruitingNCT04277377
What this trial is testing

Nanoparticle for DSA Removal

Who this might be right for
Kidney FailurePresence of Donor Specific Antibodies
University of Zurich 100
Not applicableNot Yet RecruitingNCT07456228
What this trial is testing

Emergency Stroke Unit With NeuAngio-CT (ESU-ACT)

Who this might be right for
Acute Ischemic Stroke
Beijing Tiantan Hospital 500
Not applicableStudy completedNCT06636604
What this trial is testing

Development of a Decision Support Algorithm (DSA) for Detecting the Sciatic Nerve in Safe Injection Practices

Who this might be right for
NursesInjection SiteSciatic Nerve+2 more
Sakarya University 60
Post-approval studies (Phase 4)Study completedNCT01044303
What this trial is testing

Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)

Who this might be right for
Transplant; Failure, Kidney
East Carolina University 32
Testing effectiveness (Phase 2)Study completedNCT02523430
What this trial is testing

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fuda Cancer Hospital, Guangzhou 60
Large-scale testing (Phase 3)Study completedNCT02134899
What this trial is testing

The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Assistance Publique - Hôpitaux de Paris 3
Testing effectiveness (Phase 2)Study completedNCT00707876
What this trial is testing

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

Who this might be right for
Peripheral Arterial Disease (PAD)
AMAG Pharmaceuticals, Inc. 119
Not applicableLooking for participantsNCT03607565
What this trial is testing

A New Parameter Derived From DSA to Evaluate Cerebral Perfusion

Who this might be right for
Cerebral Ischemia
Xi'an No.3 Hospital 30,000
Not applicableStudy completedNCT05304572
What this trial is testing

Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction Angiography

Who this might be right for
Hepatocellular Carcinoma
Assiut University 70
Not applicableNot Yet RecruitingNCT07824739
What this trial is testing

AI Assistance for Detecting Active Bleeding During DSA Procedures

Who this might be right for
DSABleedingAI (Artificial Intelligence)+2 more
Zhongda Hospital 1,324
Testing effectiveness (Phase 2)Study completedNCT02545556
What this trial is testing

Liver Cancer HepaSphere Combined With Cryosurgery

Who this might be right for
Liver Cancer
Fuda Cancer Hospital, Guangzhou 60
Not applicableNot Yet RecruitingNCT06769867
What this trial is testing

(Withdrawal) AI-Based Low-Dose 3D-DSA Reconstruction

Who this might be right for
Cerebrovascular Disease
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 134
Not applicableStudy completedNCT06762613
What this trial is testing

Functional Innovation and Application Research of Domestic Advanced Low-Dose DSA/CT-DSA

Who this might be right for
Lung Nodules
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 220
Not applicableStudy completedNCT04026087
What this trial is testing

Subclass of Donor-specific Antibody as a Risk Factor of Antibody Mediated Rejection in Renal Transplantation

Who this might be right for
Antibody-mediated Rejection
University Hospital, Montpellier 100
Next Page